# Miao Mo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/miao-mo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,573 |
| Field | Breast Cancer Treatment Studies |
| h-index | 31 |
| i10-index | 72 |
| Last Known Institution | Shanghai Medical College of Fudan University |
| OpenAlex ID | https://openalex.org/A5110934449 |
| ORCID iD | 0009-0008-3842-1042 |
| Works | 129 |

## Researcher papers

- [Epidemiology and genomics of prostate cancer in Asian men](https://scholariq.org/papers/epidemiology-and-genomics-of-prostate-cancer-in-asian-men/)
- [Dietary fiber intake and risk of type 2 diabetes: a dose–response analysis of prospective studies](https://scholariq.org/papers/dietary-fiber-intake-and-risk-of-type-2-diabetes-a-dose-response-analysis-of/)
- [Tumor microenvironment responsive drug delivery systems](https://scholariq.org/papers/tumor-microenvironment-responsive-drug-delivery-systems/)
- [Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer](https://scholariq.org/papers/effect-of-adjuvant-paclitaxel-and-carboplatin-on-survival-in-women-with-triple/)
- [Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1/ERβ/Bcl-2 signalling](https://scholariq.org/papers/cancer-associated-fibroblasts-promote-cisplatin-resistance-in-bladder-cancer/)
- [Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH)](https://scholariq.org/papers/randomized-phase-ii-trial-of-immunotherapy-based-total-neoadjuvant-therapy-for/)
- [Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer](https://scholariq.org/papers/long-non-coding-rna-metastasis-associated-in-lung-adenocarcinoma-transcript-1/)
- [Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial](https://scholariq.org/papers/adjuvant-capecitabine-with-docetaxel-and-cyclophosphamide-plus-epirubicin-for/)
- [Association between dietary nitrate and nitrite intake and site-specific cancer risk: evidence from observational studies](https://scholariq.org/papers/association-between-dietary-nitrate-and-nitrite-intake-and-site-specific-cancer/)
- [Breast cancer screening and early diagnosis in Chinese women](https://scholariq.org/papers/breast-cancer-screening-and-early-diagnosis-in-chinese-women/)
- [Dihydroartemisinin attenuates renal fibrosis through regulation of fibroblast proliferation and differentiation](https://scholariq.org/papers/dihydroartemisinin-attenuates-renal-fibrosis-through-regulation-of-fibroblast/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)
- [Breast Implant and Reconstruction](https://scholariq.org/topics/breast-implant-and-reconstruction/)
- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)

## Researcher university

- [Shanghai Medical College of Fudan University](https://scholariq.org/institutions/shanghai-medical-college-of-fudan-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.